BWAYBrainsway Ltd.

Nasdaq brainsway.com


$ 6.01 $ 0.05 (0.83 %)    

Friday, 28-Jun-2024 15:15:51 EDT
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 6.07
$ 6.09
$ 0.00 x 0
$ 6.09 x 150
$ 6.01 - $ 6.09
$ 2.01 - $ 7.62
29,216
na
100.89M
$ 1.19
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-brainsway-maintains-15-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $15 price tar...

 brainsway-says-fda-has-granted-expanded-indication-for-deep-transcranial-magnetic-stimulation-system

This allows for the treatment of patients with major depressive disorder (MDD) ages 22 to 86, changing the previous upper age l...

 oppenheimer-maintains-outperform-on-brainsway-raises-price-target-to-11

Oppenheimer analyst Steven Lichtman maintains BrainsWay (NASDAQ:BWAY) with a Outperform and raises the price target from $10...

 hc-wainwright--co-maintains-buy-on-brainsway-raises-price-target-to-15

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target ...

 brainsway-reiterates-fy24-revenue-guidance-of-37m-40m-est-37779m

This would represent growth of 16% to 26% over full-year 2023 revenue. In addition, it continues to anticipate that profitabili...

 brainsway-q1-sales-9095m-beat-8720m-estimate

BrainsWay (NASDAQ:BWAY) reported quarterly sales of $9.095 million which beat the analyst consensus estimate of $8.720 million ...

 brainsway-expands-deep-tms-access-in-israel-brainsway-has-steadily-increased-its-presence-in-the-country-with-11-recent-system-installations-driven-in-part-by-a-45-increase-in-reimbursement-rates

 BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasi...

 brainsway-announces-published-review-results-highlighting-potential-of-deep-tms-to-treat-parkinsons-disease

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasiv...

 hc-wainwright--co-maintains-buy-on-brainsway-raises-price-target-to-13

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target ...

 brainsway-q4-sales-903m-beat-842m-estimate

BrainsWay (NASDAQ:BWAY) reported quarterly sales of $9.03 million which beat the analyst consensus estimate of $8.42 million by...

 earnings-scheduled-for-march-6-2024

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue o...

 brainsway-earnings-preview
BrainsWay Earnings Preview
03/05/2024 18:02:20

 brainsway-announced-that-it-will-be-clinically-evaluating-its-stimulation-technology-in-two-new-feasibility-trials

The Company now aims to assess the potential clinical impact of this technology on patients in two newly launched feasibility s...